Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of $81.82 billion as of October 22, 2026. It is the 305th most valuable company in the world and the 167th biggest in the United States. Its market cap has increased by 33.84% in one year.

Market Cap

81.82B

Enterprise Value

66.70B

1-Year Change

33.84%

Global Rank

#305

Country Rank

#167 United States

ChartMarket Cap Chart

Chart

Since December 1, 1998, Regeneron Pharmaceuticals's market cap has increased from $252.00M to $81.82B, an increase of 32,367.14%. That is a compound annual growth rate of 23.03%.

Market Cap History

Date	Market Cap	% Change
Oct 21, 2026	82.95B	2.25%
Dec 31, 2025	81.12B	3.64%
Dec 31, 2024	78.28B	-18.19%
Dec 29, 2023	95.69B	21.78%
Dec 30, 2022	78.57B	15.69%
Dec 31, 2021	67.92B	31.74%
Dec 31, 2020	51.55B	25.04%
Dec 31, 2019	41.23B	1.98%
Dec 31, 2018	40.43B	0.08%
Dec 29, 2017	40.39B	4.33%
Dec 30, 2016	38.72B	-31.47%
Dec 31, 2015	56.49B	35.45%
Dec 31, 2014	41.71B	52.42%
Dec 31, 2013	27.36B	65.66%
Dec 31, 2012	16.52B	221.91%
Dec 30, 2011	5.13B	89.94%
Dec 31, 2010	2.70B	38.80%
Dec 31, 2009	1.95B	33.11%
Dec 31, 2008	1.46B	-8.46%
Dec 31, 2007	1.60B	38.55%
Dec 29, 2006	1.15B	29.12%
Dec 30, 2005	893.00M	73.94%
Dec 31, 2004	513.40M	-36.89%
Dec 31, 2003	813.50M	-0.20%
Dec 31, 2002	815.10M	-33.81%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Vertex Pharmaceuticals	127.22B
Moderna	90.58B
argenx SE	51.20B
BeOne Medicines AG	42.09B
Revolution Medicines	39.04B
Royalty Pharma	34.66B
Alnylam Pharmaceuticals	31.22B
Roivant Sciences	25.06B

Market Cap Rankings